Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion
Christopher R. McEvoy, Huiling Xu, Kortnye Smith, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 5, pp. 1940-1945
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Accurate and efficient detection of gene fusions from RNA sequencing data
Sebastian Uhrig, Julia Ellermann, Tatjana Walther, et al.
Genome Research (2021) Vol. 31, Iss. 3, pp. 448-460
Open Access | Times Cited: 330
The role of CRAF in cancer progression: from molecular mechanisms to precision therapies
Melody Riaud, Jennifer Maxwell, Isabel Soria‐Bretones, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 2, pp. 105-122
Closed Access | Times Cited: 22
Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma
Maxine Lam, Joey Aw, Damien Tan, et al.
Small (2023) Vol. 19, Iss. 52
Open Access | Times Cited: 18
Going to extremes: determinants of extraordinary response and survival in patients with cancer
Flurina A.M. Saner, Alan Herschtal, Brad H. Nelson, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 6, pp. 339-348
Open Access | Times Cited: 42
Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles
Erik A. Williams, Nikunj Shah, Meagan Montesion, et al.
Modern Pathology (2020) Vol. 33, Iss. 8, pp. 1466-1474
Open Access | Times Cited: 35
A Malignant Neoplasm From the Jejunum With aMALAT1-GLI1Fusion and 26-Year Survival History
Owen W.J. Prall, Christopher R. McEvoy, David J. Byrne, et al.
International Journal of Surgical Pathology (2020) Vol. 28, Iss. 5, pp. 553-562
Closed Access | Times Cited: 34
RAF1 rearrangements are common in pancreatic acinar cell carcinomas
Owen W.J. Prall, Violeta Nastevski, Huiling Xu, et al.
Modern Pathology (2020) Vol. 33, Iss. 9, pp. 1811-1821
Open Access | Times Cited: 34
Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine inKRASWild-Type Pancreatic Cancer
Michael Fusco, Daryoush Saeed‐Vafa, Estrella M. Carballido, et al.
JCO Precision Oncology (2021), Iss. 5, pp. 65-74
Open Access | Times Cited: 31
Identification of fusions with potential clinical significance in melanoma
Jakob M. T. Moran, Long P. Le, Valentina Nardi, et al.
Modern Pathology (2022) Vol. 35, Iss. 12, pp. 1837-1847
Open Access | Times Cited: 22
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Penglei Wang, Kyle Vaughn Laster, Xuechao Jia, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11
RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma‐like mesenchymal tumors
Marialetizia Motta, Sabina Barresi, Simone Pizzi, et al.
The Journal of Pathology (2024) Vol. 263, Iss. 2, pp. 166-177
Closed Access | Times Cited: 4
RAF1‐rearranged spindle cell neoplasm: a clinicopathological and molecular genetic study of six cases with review of the literature
Peipei Zhu, Xuewei Zeng, Linjie Yang, et al.
Histopathology (2025)
Closed Access
Genomic profiling and personalized treatment strategies for skin malignancies: findings from the center for cancer genomics and advanced therapeutics database
Tokimasa Hida
International Journal of Clinical Oncology (2025)
Closed Access
Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domains
Florian Weinberg, Ricarda Griffin, Martina Fröhlich, et al.
Oncogene (2019) Vol. 39, Iss. 4, pp. 814-832
Closed Access | Times Cited: 27
Genomic landscape of cutaneous, acral, mucosal, and uveal melanoma in Japan: analysis of clinical comprehensive genomic profiling data
Tokimasa Hida, Junji Kato, Masashi Idogawa, et al.
International Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 3
Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers
Andrew Rankin, Adrienne Johnson, Alison Roos, et al.
The Oncologist (2020) Vol. 26, Iss. 1, pp. e153-e163
Open Access | Times Cited: 22
Topical 2′-Hydroxyflavanone for Cutaneous Melanoma
Chhanda Bose, Sharda P. Singh, Henry Palangdao Igid, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1556-1556
Open Access | Times Cited: 16
RAF1 Gene Fusions as a Possible Driver Mechanism in Rare BAP1-Inactivated Melanocytic Tumors: A Report of 2 Cases
Michele Donati, Petr Martínek, Liubov Kastnerova, et al.
American Journal of Dermatopathology (2020) Vol. 42, Iss. 12, pp. 961-966
Closed Access | Times Cited: 15
Lung Adenocarcinoma With Primary LIMD1-BRAF Fusion Treated With MEK Inhibitor: A Case Report
Chengyou Wang, Jiun‐Yi Hsia, Che-Hsing Li, et al.
Clinical Lung Cancer (2021) Vol. 22, Iss. 6, pp. e878-e880
Open Access | Times Cited: 11
Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway Activation
Katherine T. Lind, Hannah Chatwin, John DeSisto, et al.
Journal of Neuropathology & Experimental Neurology (2021) Vol. 80, Iss. 12, pp. 1099-1107
Open Access | Times Cited: 11
Sustained Response to the Mitogen-Activated Extracellular Kinase Inhibitor Trametinib in a Spindle Cell Sarcoma Harboring a QKI-RAF1 Gene Fusion
François Panet, Sungmi Jung, Thierry Alcindor
JCO Precision Oncology (2022), Iss. 6
Open Access | Times Cited: 8
Clinical response under MEK inhibitor alone in metastatic melanoma with a novel fusion involving the RAF1 gene
M. Boileau, C. Descarpentries, Guillaume Delzenne, et al.
Melanoma Research (2023) Vol. 33, Iss. 3, pp. 247-251
Closed Access | Times Cited: 4
Aurora kinase A regulates cancer-associated RNA aberrant splicing in breast cancer
Sisi Li, Yangfan Qi, Jiachuan Yu, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e17386-e17386
Open Access | Times Cited: 4
Effectiveness Treatment of a BRAF-ZKSCAN5 Fusion Gene Melanoma Case with Dabrafenib/Trametinib
Hiroshi Kato, Shinji Kano, Yukiko Yasui, et al.
Case Reports in Oncology (2023) Vol. 16, Iss. 1, pp. 1007-1012
Open Access | Times Cited: 4
Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions
Ying‐Hsia Chu, Nora Katabi, Purvil Sukhadia, et al.
Histopathology (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top